Mylan N Price Prediction and Hype Density Breakdown

MYL -- USA Stock  

USD 19.03  0.14  0.73%

We analyze noise-free headlines and recent hype associated with Mylan N V which may create opportunities for some arbitrage if properly timed. With Mylan N hype-based prediction module you can estimate the value of Mylan N V from the prospective of Mylan N response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Mylan N over a specific investment horizon. Please see also Mylan N Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Mylan N After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Mylan N Estimiated After-Hype Price Volatility

May 24, 2019
Current Value
After-hype Price
Mylan N is somewhat reliable asset. Analysis and calculation of next after-hype price of Mylan N V is based on 2 months time horizon.

Mylan N Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.79% 4.01% 0.45%  0.08% 9 Events / Month3 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Mylan N Hype Timeline

On 24 of May Mylan N V is traded for 19.03. The entity has historical hype elasticity of 0.45 and average elasticity to hype of competition of 0.08. Mylan N V is estimated to increase in value after the next headline with price going to jump to 19.48. The average volatility of media hype impact on the company stock price is about 703.51%. The price escalation on the next news is anticipated to be 2.36% where as daily expected return is now at -0.79%. The volatility of related hype on Mylan N is about 3811.79% with expected price after next announcement by competition of 19.11. The company has 13.98B in debt with debt to equity (D/E) ratio of 117.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Considering 30-days investment horizon, the next estimated press release will be in about 9 days.
Please see also Mylan N Basic Forecasting Models to cross-verify your projections.

Mylan N Related Hype Analysis

At Risk
Diplomat Pharmacy 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
DURECT Corporation 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Eagle Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Elanco Animal Health 0.45 6 per month 1.11  0.0211  2.00 (2.01)  6.88 
Endo International plc 0.44 10 per month 0.00 (0.16)  3.04 (4.69)  25.45 
Evolus 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ESSA Pharma 0.18 6 per month 0.00 (0.14)  8.22 (11.91)  29.21 
Evoke Pharma(0.018) 6 per month 0.00 (0.18)  6.85 (10.71)  60.39 
Fibrocell Science 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Flexion Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Please see also Mylan N Basic Forecasting Models to cross-verify your projections. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.